Your browser doesn't support javascript.
loading
COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases.
Ayhan, Erhan; Öztürk, Murat; An, Isa; BekçIbasi, Muhammed.
Affiliation
  • Ayhan E; Department of Dermatology, University of Health Sciences Gazi Yasargil Education and Research Hospital, Diyarbakir, Turkey.
  • Öztürk M; Department of Dermatology, Van Education and Research Hospital, Van, Turkey.
  • An I; Department of Dermatology, Sanliurfa Education and Research Hospital, Sanliurfa, Turkey.
  • BekçIbasi M; Department of Infectious Diseases and Clinical Microbiology, Bismil State Hospital, Diyarbakir, Turkey.
Int J Dermatol ; 60(2): 253-254, 2021 Feb.
Article in En | MEDLINE | ID: mdl-33332576
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab / Chronic Urticaria / COVID-19 Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Int J Dermatol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Omalizumab / Chronic Urticaria / COVID-19 Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Int J Dermatol Year: 2021 Document type: Article Affiliation country: Country of publication: